PneumRx is conducting an FDA-approved clinical study to evaluate the safety and effectiveness of a medical device for patients with emphysema: the RePneu® (say ‘RENEW’) Lung Volume Reduction Coil. Coils are placed in the airways of the lung and work by compressing diseased portions of the lung, helping small airways stay open, so that breathing becomes easier and healthier parts of the lung can function more efficiently.
Over 500 patients have been successfully treated in European clinical studies and routine clinical practice. Patients treated with RePneu Coils may experience reduced breathlessness, improvements in their quality of life, ability to exercise, and/or lung function.
Up to 315 patients will participate in the RENEW Study, conducted in over 25 medical centers across North America, with a smaller number of sites in Europe.
Please visit www.clinicaltrials.gov search: RENEW or click on any of the links below to learn more about the RENEW Study.
RePneu LVRC is limited by U.S. law to investigational use only in the USA